Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-30

Clinical Trial Update: Kidney Damage in Patients With Moderate Fall in eGFR [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting kidney damage in patients with moderate drop in eGFR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Coronary Artery Stenosis | Phase 4 | Status: COMPLETED | Results posted: 2013-12-30